Islets Have a Lot of Nerve! Or Do They?  by Taborsky, Gerald J.
Cell Metabolism
PreviewsIslets Have a Lot of Nerve! Or Do They?Gerald J. Taborsky, Jr.1,*
1VA Puget Sound Health Care System and the University of Washington, Seattle, WA 98108, USA
*Correspondence: taborsky@u.washington.edu
DOI 10.1016/j.cmet.2011.06.004
The autonomic nervous system influences insulin and glucagon secretion. In this issue, Rodriguez-Diaz et al.
(2011) show that mouse and human islets differ in their innervation patterns, yet the effect of neural activation
on islet hormone secretion is similar. Key questions raised by this species difference have potential relevance
to diabetic therapeutics.Neural Control of the Islet
Glucagon and insulin are secreted from
islet alpha and beta cells, respectively,
and have major effects on metabolism.
Circulating metabolites in turn control
the secretion of these hormones. The
landmark review of Woods and Porte
(Woods and Porte, 1974) summarized
the early evidence that autonomic nerves
also influence pancreatic hormone secre-
tion. Later, animal studies established
that sympathetic nerves inhibit insulin
and stimulate glucagon secretion and
that parasympathetic nerves markedly
stimulate insulin and modestly stimulate
glucagon secretion (Ahre´n, 2000). These
effects were assumed to be due to the
release of neurotransmitters directly onto
alpha and beta cells. However, the finding
of Rodriguez-Diaz et al. (2011) that islet
nerves in humans do not contact alpha
or beta cells suggests that neural regula-
tion of islet hormone secretion is not so
straightforward.
The sophisticated and detailed studies
of Rodriguez-Diaz et al. (2011) advance
our understanding of the neuroanatomy
of the islet in two major ways. First, they
determine whether islet nerves actually
contact blood vessels, alpha cells, or
beta cells by coupling immunohistochem-
istry for neural, islet cell, and blood vessel
markers with confocal microscopy.
Second, they provide the first detailed
description of the neuroanatomy of the
human islet based on high-quality sam-
ples of human pancreas, which gives
credence to their conclusions. In the
mouse islet they find that sympathetic
fibers preferentially innervate alpha cells
and that parasympathetic fibers innervate
alpha cells and beta cells equally. In
marked contrast, they find in the human
islet that sympathetic fibers preferentially
innervate central islet blood vessels andthat parasympathetic fibers are few and
far between, a conclusion hedged some-
what by the extensive coexpression of
their parasympathetic marker in islet
endocrine cells.
The Physiologic Role of Islet Nerves
Although the animal studies mentioned
above demonstrate that nerves can
influence islet hormone secretion, they
did not establish when they actually
do so. Studies measuring norepinephrine
spillover demonstrated that pancreatic
sympathetic nerves were activated by
hypoglycemic stress, but not by either
hypoxic or hypotensive stress (Havel
et al., 1988). Analogous measurements
of acetylcholine spillover from parasym-
pathetic nerves are rarely possible
becauseof avidandubiquitous acetylcho-
linesterases. Fortunately, pancreatic poly-
peptide, secreted from the islet F cell, was
found to be under strong parasympathetic
control (Schwartz et al., 1978). Use of this
surrogate established that pancreatic
parasympathetic nerves are activated
during both hypoglycemia and feeding.
Studies using autonomic blockade or
ablation established autonomic media-
tion of the glucagon response to severe
hypoglycemia (Taborsky et al., 1998).
This increased glucagon secretion helps
to restore euglycemia by stimulating
hepatic glucose production. Studies using
vagotomy or cholinergic antagonists sug-
gested that parasympathetic nerves help
mediate the very early insulin response
to feeding (Ahre´n, 2000), which primes
the liver to store the incoming glucose
load.
Human versus Animal Studies
The finding that the endocrine cells of
the human islet are not directly innervated
raises the question of whether the conclu-Cell Metabosions derived from animal studies apply
to humans. However, three representative
studies of neural control of the islet in
humans produce results similar to those
in animals. First, the insulin response to
the cephalic phase of feeding (Teff et al.,
1991) is parasympathetically mediated
in humans, as it is in animals (Ahre´n,
2000). Second, autonomic blockade elim-
inates 75% of the glucagon response to
insulin-induced hypoglycemia in humans
(Havel and Ahre´n, 1997), just as it does
in animals (Taborsky et al., 1998). Third,
activation of sympathetic nerves inhibits
insulin secretion in humans (Gilliam
et al., 2007), as it does in animals (Ahre´n,
2000). Given the differences in islet inner-
vation between mice and humans, it is
likely that animals and humans use
different mechanisms to achieve similar
autonomic effects on pancreatic hormone
secretion.
Mechanisms of Neural Control
In mice it is likely that activation of islet
sympathetic nerves inhibits insulin secre-
tion by releasing norepinephrine directly
onto the islet beta cell. In contrast, the
authors suggest two indirect mechanisms
for this inhibition of insulin in humans: (1)
a decrease of islet blood flow or (2) a spill-
over of norepinephrine into the arteriole
that perfuses the islet. Although a de-
crease of islet blood flow could explain
a decrease of insulin secretion, it cannot
easily explain a simultaneous increase of
glucagon secretion, like that seen in
animals. Regarding the norepinephrine
spillover mechanism, there is precedent
in another organ under sympathetic con-
trol, the liver. Low frequencies of sympa-
thetic nerve stimulation, which are insuffi-
cient to increase hepatic norepinephrine
spillover, do not increase hepatic glucose
production. They do decrease hepaticlism 14, July 6, 2011 ª2011 Elsevier Inc. 5
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Previewsarterial blood flow, suggesting that the
norepinephrine is released at the arteriole.
In contrast, frequencies of nerve stimula-
tion high enough to increase norepineph-
rine spillover do stimulate hepatic glucose
production (Mundinger et al., 1997).
These data suggest that sympathetic
nerves can influence downstream targets
by releasing their neurotransmitters into
the perfusing arteriole.
In contrast, it is unlikely that acetyl-
choline spillover mediates the effect of
parasympathetic activation to stimulate
insulin secretion in humans because of
their rapid degradation by acetycholines-
terases. However, vagal-mediated re-
lease of gastrointestinal hormones could
stimulate insulin release indirectly.
Implications and Future Studies
The discovery and elucidation of these
indirect mechanisms of neural control
of the human islet will yield new insight
into modulation of alpha and beta cell
function, with the potential to influence
future diabetic therapeutics. For example,6 Cell Metabolism 14, July 6, 2011 ª2011 Elsunderstanding how autonomic activation
mediates the glucagon response to hypo-
glycemia in humans may provide a way to
correct the impaired response seen in
type 1 diabetes. Treatment-induced hy-
poglycemia, which is a major barrier to
patient compliance with intensive insulin
therapy, may thus be avoided. Likewise,
understanding how activation of the
parasympathetic nervous system helps
mediate early insulin responses to feeding
in humans may provide a way to augment
these responses and thereby avoid the
glucose intolerance which precedes type
2 diabetes. Thus, the elegant studies of
Rodriguez-Diaz et al. are not only a major
advance for the academic field of neural
control of the islet, but also raise here-
tofore unrecognized questions whose
answers may impact the treatment of
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